Cancer Biology & Epidemiology
Avoiding immune destruction
Evading growth suppressors
Enabling replicative immortality
Tumor-promoting inflammation
Activating invasion and metastasis
Genomic instability
Inducing angiogenesis
Resisting cell death
Deregulating cellular energetics
Sustaining proliferative signaling
Benign: -oma
Malignant epithelial tissue: -carcinoma
Malignant connective tissue: -sarcoma
Fatty tissue: lip-
Gland tissue: adeno-
Fibrous tissue: fibro-
Bone: osteo-
Cartilage: chondro-
Blood vessel: hemangio-
Smooth muscle: leiomyo-
Striated muscle: rhabdomyo-
Hodgkinās lymphoma
Wilmsā tumor
Ewing sarcoma
Melanoma ā malignant
Heptamoa ā carcinoma
2 genes, 1 that promotes, 1 that represses; when either one is defective, they both cause uncontrolled cell growth
Signaling genes:
Proto-oncogenes (RAS, MYC); normal cell proliferation
Oncogenes (oncoproteins); mutated proto-oncogenes, uncontrolled cell growth
DNA repair genes:
BRCA1: chromosome 17
BRCA2: chromosome 13
Can be spontaneous or heritable
Apoptosis genes:
BAX
BCL-2
These are defective cells that favor cell survival when it should be programmed cell death
Regulate cell cycle, inhibit cell proliferation, stop cell division, and prevent mutations (normally)
Governors: prevent bad things from happening, but the ābrakeā on
Guardians: like the police, tag the bad things, and monitor; damage control
P53, APC
Growth of new vessels
Vascular endothelial growth factor (VEGF)
Cancer can create new routes of energy/life for itself so it creates more blood vessels to keep it alive
Avastin stops the growth of blood vessels
Use of glycolysis under normal oxygen conditions, aerobic glycolysis and oxidative phosphorylation
For every 1 glucose = 1 ATP; completely shuns the mitochondria
Allows rapid cell growth
Activated by oncogenes and mutant tumor suppressors
LACTATE = LAZY
Doesnāt shun the mitochondria
Tumor cells can demand for other cells to make extra lactate to keep them fed, hence, reprograms the other cellās metabolism
Makes other cells do the work for the tumor
A patient comes in and the cancer is removed surgically
After surgery, day 0 begins
If the cancer came back within 1 year, the chance of survival from the specific cancer is lowered
If the cancer did NOT come back, there is a higher chance of survival to 5 years
How far has the cancer spread?
Stage I: No metastasis
Stage II: Local invasion
Stage III: Spread to regional structures
Stage IV: Distant metastasis
ā Universal system
T: Tumor spread (T-T3)
N: Node involvement (N-N2)
Metastasis: Metastases (M-M2)
Dukeās A: stage I, no metastasis
5 yr survival >90%
Dukeās B: stage II, local invasion
5 yr survival 55% to 85%
Dukeās C: stage III, spread to regional structures
5 yr survival 20% to 55%
Dukeās D: stage IV, distant metastasis
5 yr survival <5%
How bad do the cells look?
Low grade/grade I: well differentiated, normal tissue
Intermediate/grade II: moderately differentiated
High grade/grade III: poorly differentiated, may begin to act more aggressively
High grade/grade IV: undifferentiated, high degree of anaplasia
Anemia
Fatigue
Cachexia
Leukpenia
Thrombocytopenia
Infection
Skin and hair changes
GI manifestations
Paraneoplastic symptoms
Unusual bleeding
Changes in bowel or bladder habits
Change in a wart or mole
A sore that does not heal
Unexplained weight loss
Anemia, low hemoglobin, persistent fatigue
Persistent cough, hoarseness without reason
A solid lump, often painless (most commonly in the breast or testes)
T: Tumor spread
T0= breast free of tumor
T1= lesion <2cm
T2= lesion 2-5 cm
T3= skin/chest wall involved by invasion
N: Node involvement
N0= no axillary nodes involved
N1= mobile nodes involved
N2= fixed nodes involved
M: presence of distant metastasis
M0= no metastases
M1= demonstrated metastases
M2= metastases confirmed
Avoiding immune destruction
Evading growth suppressors
Enabling replicative immortality
Tumor-promoting inflammation
Activating invasion and metastasis
Genomic instability
Inducing angiogenesis
Resisting cell death
Deregulating cellular energetics
Sustaining proliferative signaling
Benign: -oma
Malignant epithelial tissue: -carcinoma
Malignant connective tissue: -sarcoma
Fatty tissue: lip-
Gland tissue: adeno-
Fibrous tissue: fibro-
Bone: osteo-
Cartilage: chondro-
Blood vessel: hemangio-
Smooth muscle: leiomyo-
Striated muscle: rhabdomyo-
Hodgkinās lymphoma
Wilmsā tumor
Ewing sarcoma
Melanoma ā malignant
Heptamoa ā carcinoma
2 genes, 1 that promotes, 1 that represses; when either one is defective, they both cause uncontrolled cell growth
Signaling genes:
Proto-oncogenes (RAS, MYC); normal cell proliferation
Oncogenes (oncoproteins); mutated proto-oncogenes, uncontrolled cell growth
DNA repair genes:
BRCA1: chromosome 17
BRCA2: chromosome 13
Can be spontaneous or heritable
Apoptosis genes:
BAX
BCL-2
These are defective cells that favor cell survival when it should be programmed cell death
Regulate cell cycle, inhibit cell proliferation, stop cell division, and prevent mutations (normally)
Governors: prevent bad things from happening, but the ābrakeā on
Guardians: like the police, tag the bad things, and monitor; damage control
P53, APC
Growth of new vessels
Vascular endothelial growth factor (VEGF)
Cancer can create new routes of energy/life for itself so it creates more blood vessels to keep it alive
Avastin stops the growth of blood vessels
Use of glycolysis under normal oxygen conditions, aerobic glycolysis and oxidative phosphorylation
For every 1 glucose = 1 ATP; completely shuns the mitochondria
Allows rapid cell growth
Activated by oncogenes and mutant tumor suppressors
LACTATE = LAZY
Doesnāt shun the mitochondria
Tumor cells can demand for other cells to make extra lactate to keep them fed, hence, reprograms the other cellās metabolism
Makes other cells do the work for the tumor
A patient comes in and the cancer is removed surgically
After surgery, day 0 begins
If the cancer came back within 1 year, the chance of survival from the specific cancer is lowered
If the cancer did NOT come back, there is a higher chance of survival to 5 years
How far has the cancer spread?
Stage I: No metastasis
Stage II: Local invasion
Stage III: Spread to regional structures
Stage IV: Distant metastasis
ā Universal system
T: Tumor spread (T-T3)
N: Node involvement (N-N2)
Metastasis: Metastases (M-M2)
Dukeās A: stage I, no metastasis
5 yr survival >90%
Dukeās B: stage II, local invasion
5 yr survival 55% to 85%
Dukeās C: stage III, spread to regional structures
5 yr survival 20% to 55%
Dukeās D: stage IV, distant metastasis
5 yr survival <5%
How bad do the cells look?
Low grade/grade I: well differentiated, normal tissue
Intermediate/grade II: moderately differentiated
High grade/grade III: poorly differentiated, may begin to act more aggressively
High grade/grade IV: undifferentiated, high degree of anaplasia
Anemia
Fatigue
Cachexia
Leukpenia
Thrombocytopenia
Infection
Skin and hair changes
GI manifestations
Paraneoplastic symptoms
Unusual bleeding
Changes in bowel or bladder habits
Change in a wart or mole
A sore that does not heal
Unexplained weight loss
Anemia, low hemoglobin, persistent fatigue
Persistent cough, hoarseness without reason
A solid lump, often painless (most commonly in the breast or testes)
T: Tumor spread
T0= breast free of tumor
T1= lesion <2cm
T2= lesion 2-5 cm
T3= skin/chest wall involved by invasion
N: Node involvement
N0= no axillary nodes involved
N1= mobile nodes involved
N2= fixed nodes involved
M: presence of distant metastasis
M0= no metastases
M1= demonstrated metastases
M2= metastases confirmed